Investment Summary

Aurora Invests In Medical Marijuana

On March 4, 2019, Aurora invested in consumer products company Medical Marijuana from Cronos Group

Investment Highlights
  • This is Aurora’s 1st transaction in the Consumer Products sector.
  • This is Aurora’s 7th transaction in Canada.
  • This is Aurora’s 2nd transaction in British Columbia.

Investment Summary
Date 2019-03-04
Target Medical Marijuana
Sector Consumer Products
Investor(s) Aurora
Sellers(s) Cronos Group
Deal Type Stake Purchase

Target

Medical Marijuana

Whistler, British Columbia, Canada
Medical Marijuana Corp. growing legal medical cannabis with the approval of Health Canada. We have always believed our medication should be organic, and since sowing our first seeds have been growing our plants naturally. Without giving too much away, our process is truly a labour of love. From cutting through to drying, each plant is individually watered, pruned and trimmed by BC’s finest hands to ensure consistency and quality.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Aurora

Edmonton, Alberta, Canada
Category Company
Founded 2013
Sector Life Science
Employees1,073
Revenue 270M CAD (2023)
DESCRIPTION

Aurora is a Canadian company and licensed producer of artisanal medical marijuana pursuant to the Marihuana for Medical Purposes Regulations. Aurora was founded in 2013 and is based in Edmonton, Alberta.

DEAL STATS #
Overall 9 of 13
Sector (Consumer Products) 1 of 3
Type (Stake Purchase) 1 of 1
State (British Columbia) 2 of 3
Country (Canada) 7 of 10
Year (2019) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-12-10 Farmacias Magistrales S.A.

Mexico

Farmacias Magistrales S.A. is an importer of raw materials containing THC, the active ingredient in marijuana. It will distribute medical cannabis products containing over 1 percent THC, apparently through health care professionals.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-25 Chemi Pharmaceutical

Mississauga, Ontario, Canada

Chemi Pharmaceutical, Inc. is a GMP quality control analytical laboratory company. Chemi Pharmaceutical specializing in pharmaceutical, veterinary, natural health products analysis and development/validation of analytical methods. Chemi Pharmaceutical, Inc. was founded in 2001 and is based in Mississauga, Ontario.

Buy -

Seller(S) 1

SELLER

Cronos Group

Toronto, Ontario, Canada
Category Company
Founded 2012
Sector Consumer Products
Employees356
Revenue 87M USD (2023)
DESCRIPTION

Cronos Group is a globally diversified and vertically integrated cannabis company with a presence across four continents. Cronos Group was incorporated in 2012 and is headquartered in Toronto, Canada.

DEAL STATS #
Overall 1 of 1
Sector (Consumer Products) 1 of 1
Type (Stake Purchase) 1 of 1
State (British Columbia) 1 of 1
Country (Canada) 1 of 1
Year (2019) 1 of 1
Mergr

Product

Company

Legal